- Home
- EVM vs BWAY Comparison
EVM vs BWAY Comparison
Compare EVM & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- BWAY
- Stock Information
- Founded
- EVM 2002
- BWAY 2003
- Country
- EVM United States
- BWAY Israel
- Employees
- EVM N/A
- BWAY N/A
- Industry
- EVM Finance/Investors Services
- BWAY Medical/Dental Instruments
- Sector
- EVM Finance
- BWAY Health Care
- Exchange
- EVM Nasdaq
- BWAY Nasdaq
- Market Cap
- EVM 219.2M
- BWAY 207.4M
- IPO Year
- EVM N/A
- BWAY 2019
- Fundamental
- Price
- EVM $9.02
- BWAY $8.76
- Analyst Decision
- EVM
- BWAY Strong Buy
- Analyst Count
- EVM 0
- BWAY 3
- Target Price
- EVM N/A
- BWAY $13.17
- AVG Volume (30 Days)
- EVM 55.8K
- BWAY 24.4K
- Earning Date
- EVM 01-01-0001
- BWAY 05-13-2025
- Dividend Yield
- EVM 4.01%
- BWAY N/A
- EPS Growth
- EVM N/A
- BWAY N/A
- EPS
- EVM 0.20
- BWAY 0.06
- Revenue
- EVM N/A
- BWAY $41,016,000.00
- Revenue This Year
- EVM N/A
- BWAY $351.53
- Revenue Next Year
- EVM N/A
- BWAY $21.84
- P/E Ratio
- EVM $47.61
- BWAY $57.37
- Revenue Growth
- EVM N/A
- BWAY 29.04
- 52 Week Low
- EVM $7.67
- BWAY $5.13
- 52 Week High
- EVM $9.59
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- EVM 51.18
- BWAY 47.80
- Support Level
- EVM $8.89
- BWAY $8.61
- Resistance Level
- EVM $9.14
- BWAY $9.09
- Average True Range (ATR)
- EVM 0.13
- BWAY 0.38
- MACD
- EVM 0.04
- BWAY 0.05
- Stochastic Oscillator
- EVM 73.33
- BWAY 58.73
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.